Binding of E2 occurs at the CD81 LEL and binding of E2 to CD81, or infections with HCVpp or HCVcc, are inhibited with pretreatment with CD81 LEL or antibody versus CD81 [34,36,47,76,77]. Here, CD81 is linked to infection.